TNF blockers not associated with poorer pregnancy outcomesNovember 14, 2023Psoriatic ArthritisPsoriasis
The challenges of palmoplantar pustulosis and other acral psoriatic diseaseNovember 10, 2023PsoriasisPsoriatic ArthritisRare Diseases
Review estimates acne risk with JAK inhibitor therapyNovember 9, 2023AcnePsoriasisAtopic DermatitisPsoriatic ArthritisHair & Nails
Researchers tease apart multiple biologic failure in psoriasis, PsANovember 8, 2023PsoriasisPsoriatic Arthritis
Most patients with psoriasis not engaged in highly shared decision-makingNovember 3, 2023PsoriasisPsoriatic ArthritisBusiness of Medicine
FDA OKs first ustekinumab biosimilarNovember 1, 2023Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
FDA approves abatacept for pediatric patients with psoriatic arthritisNovember 1, 2023Psoriatic ArthritisPediatrics
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indicationsNovember 1, 2023Atopic DermatitisPsoriasisPsoriatic ArthritisHair & NailsMedical DermatologyPigmentation Disorders
Psoriatic disease: Researchers seek a PsA diagnostic test, phenotype-targeted treatmentOctober 24, 2023Psoriatic ArthritisPsoriasis
FDA approves bimekizumab for moderate to severe plaque psoriasis in adultsOctober 19, 2023PsoriasisPsoriatic Arthritis
Pilot study: High-dose IL-23 inhibition shows promise for psoriasis remission in some patientsOctober 19, 2023PsoriasisPsoriatic Arthritis
Roflumilast side effect benefits patients with psoriasis and overweight/obesityOctober 16, 2023PsoriasisPsoriatic Arthritis
Pediatric psoriasis: Black children, males more likely to have palmoplantar subtype, study findsOctober 12, 2023PsoriasisPediatricsPsoriatic ArthritisDiversity in Medicine
Intravenous formulation of secukinumab gets FDA approvalOctober 10, 2023Psoriatic ArthritisPediatricsPsoriasis
